Literature DB >> 33780077

Intracranial Foreign Body Granuloma Mimicking Brain Tumor Recurrence: A Case Series.

Sebastian F Winter1,2,3, Deborah A Forst1,2, Derek H Oakley4, Tracy T Batchelor5, Jorg Dietrich1,2.   

Abstract

BACKGROUND: Intracranial foreign body granuloma (FBG) is a rare inflammatory reaction to retained foreign material, manifesting acutely or months to years following neurosurgical procedures. Radiographically, FBG can mimic tumor progression, and tissue biopsy may be required to guide management.
MATERIALS AND METHODS: In this retrospective case series, we present unique clinico-radiographic and histopathological features of six neuro-oncological patients diagnosed with FBG between 2007 and 2019.
RESULTS: All six patients (4 women and 2 men, aged 29-54 [median, 30.5] years) had undergone surgical resection of a low- (n = 4) or high-grade (n = 2) glioma. FBG manifestation postsurgery ranged from 1 day to 4 years and was predominantly asymptomatic (n = 5/6). Magnetic resonance imaging universally demonstrated one or multiple peripherally enhancing lesion(s) adjacent to the resection cavity. Histopathology in all (n = 4/4) resected specimens demonstrated an inflammatory reaction to foreign material, confirming FBG.
CONCLUSION: Intracranial FBG constitutes a rare but challenging treatment-related condition effectively managed by surgery, with important therapeutic implications in neuro-oncology.
© 2021 AlphaMed Press.

Entities:  

Mesh:

Year:  2021        PMID: 33780077      PMCID: PMC8100550          DOI: 10.1002/onco.13766

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  8 in total

1.  Foreign Body Granuloma After Cranial Surgery: A Systematic Review of Reported Cases.

Authors:  Ali Akhaddar; Ahmet T Turgut; Mehmet Turgut
Journal:  World Neurosurg       Date:  2018-09-27       Impact factor: 2.104

2.  Foreign body reaction to hemostatic materials mimicking recurrent brain tumor. Report of three cases.

Authors:  K F Kothbauer; G I Jallo; J Siffert; E Jimenez; J C Allen; F J Epstein
Journal:  J Neurosurg       Date:  2001-09       Impact factor: 5.115

3.  Textiloma resembling anaplastic progression of an isocitrate dehydrogenase 1 (IDH1) mutant, low grade glioma.

Authors:  Mark Daniel Anderson; Aditya Raghunathan; Mark R Gilbert
Journal:  J Neurooncol       Date:  2012-12-01       Impact factor: 4.130

4.  Textiloma (gossypiboma) mimicking recurrent intracranial tumor.

Authors:  Teresa Ribalta; Ian E McCutcheon; Antonio G Neto; Deepali Gupta; A J Kumar; David A Biddle; Lauren A Langford; Janet M Bruner; Norman E Leeds; Gregory N Fuller
Journal:  Arch Pathol Lab Med       Date:  2004-07       Impact factor: 5.534

5.  Intracranial foreign material granulomas after cranial surgery.

Authors:  Shadi Al-Afif; Gökce Hatipoglu Majernik; Elvis Josef Hermann; Majid Esmaeilzadeh; Christian Hartmann; Joachim K Krauss
Journal:  Acta Neurochir (Wien)       Date:  2018-09-06       Impact factor: 2.216

6.  Textiloma (gossypiboma) mimicking recurrent intracranial abscess.

Authors:  Aykut Akpinar; Necati Ucler; Cengiz Omer Ozdemir
Journal:  BMC Res Notes       Date:  2015-08-30

7.  Postoperative Textiloma Mimicking Intracranial Rebleeding in a Patient with Spontaneous Hemorrhage: Case Report and Review of the Literature.

Authors:  Nicola Montemurro; Domenico Murrone; Bruno Romanelli; Aldo Ierardi
Journal:  Case Rep Neurol       Date:  2020-01-09

8.  Defining Treatment-Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment-Induced Necrosis.

Authors:  Sebastian F Winter; Eugene J Vaios; Alona Muzikansky; Maria Martinez-Lage; Marc R Bussière; Helen A Shih; Jay Loeffler; Philipp Karschnia; Franziska Loebel; Peter Vajkoczy; Jorg Dietrich
Journal:  Oncologist       Date:  2020-06-18
  8 in total
  1 in total

1.  Bone Fragment Granuloma Mimicking a Brain Tumor Following Placement of an Intracranial Pressure Monitoring System.

Authors:  Orlando De Jesus; Ricardo J Fernández-de Thomas
Journal:  Cureus       Date:  2021-06-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.